Longevity
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Joint influence of small-effect genetic variants on human longevity.
|
20834067 |
2010 |
Serum albumin measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
A genome-wide assessment of variability in human serum metabolism.
|
23281178 |
2013 |
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5
|
0.600 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
De Novo Mutations in SLC1A2 and CACNA1A Are Important Causes of Epileptic Encephalopathies.
|
27476654 |
2016 |
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5
|
0.600 |
GeneticVariation
|
phenotype |
UNIPROT |
Hyperglycosylation and reduced GABA currents of mutated GABRB3 polypeptide in remitting childhood absence epilepsy.
|
18514161 |
2008 |
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5
|
0.600 |
GeneticVariation
|
phenotype |
UNIPROT |
GABRB3 mutation, G32R, associated with childhood absence epilepsy alters α1β3γ2L γ-aminobutyric acid type A (GABAA) receptor expression and channel gating.
|
22303015 |
2012 |
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
De novo mutations in epileptic encephalopathies.
|
23934111 |
2013 |
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Epileptic encephalopathy de novo GABRB mutations impair γ-aminobutyric acid type A receptor function.
|
26950270 |
2016 |
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
De novo mutations in moderate or severe intellectual disability.
|
25356899 |
2014 |
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Improving diagnosis and broadening the phenotypes in early-onset seizure and severe developmental delay disorders through gene panel analysis.
|
26993267 |
2016 |
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Diagnostic Targeted Resequencing in 349 Patients with Drug-Resistant Pediatric Epilepsies Identifies Causative Mutations in 30 Different Genes.
|
27864847 |
2017 |
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
De Novo Mutations in SLC1A2 and CACNA1A Are Important Causes of Epileptic Encephalopathies.
|
27476654 |
2016 |
Depressive disorder
|
0.430 |
Biomarker
|
disease |
PSYGENET |
Recently, microsatellite polymorphisms have been reported to be associated with four genes, GABRB3, MAOB, PAH, and SLC6A4, and their relationships have been tested to five symptom factors: hallucinations, delusions, negative symptoms, mania, and depression.
|
22414661 |
2012 |
Depressive disorder
|
0.430 |
Biomarker
|
disease |
PSYGENET |
The rs4906902 G allele of the GABRB3 gene was overrepresented in mTLE patients with depression; individuals homozygous for the G allele showed reduced GABRB3 mRNA expression.
|
22082659 |
2011 |
Depressive disorder
|
0.430 |
Biomarker
|
disease |
PSYGENET |
Patients carrying the GABRB3 G1+ allele showed stronger AE relating to negative affective change (for example, increased depression) than their GABRB3 G1- counterparts.
|
15296817 |
2004 |
Depressive disorder
|
0.430 |
Biomarker
|
disease |
PSYGENET |
In conclusion, the present study indicates that in a population of PTSD patients, heterozygosity of the GABRB3 major (G1) allele confers higher levels of somatic symptoms, anxiety/insomnia, social dysfunction and depression than found in homozygosity.
|
11711165 |
2001 |
Depressive disorder
|
0.430 |
Biomarker
|
disease |
PSYGENET |
We tested four genes [phenylalanine hydroxylase (PAH), the serotonin transporter (SLC6A4), monoamine oxidase B (MAOB), and the gamma-aminobutyric acid A receptor beta-3 subunit (GABRB3)] for their impact on five schizophrenia symptom factors: delusions, hallucinations, mania, depression, and negative symptoms.
|
19268543 |
2009 |
Schizophrenia
|
0.370 |
Biomarker
|
disease |
PSYGENET |
These results provide additional evidence that GABRB3 and MAOB/NDP gene regions might constitute risk factors for hallucinations and delusions in schizophrenia.
|
22414661 |
2012 |
Schizophrenia
|
0.370 |
Biomarker
|
disease |
PSYGENET |
We resequenced the promoter and all the exonic regions of the GABRB3 gene in 349 patients with schizophrenia and 386 control participants from Taiwan using the Sanger sequencing method.
|
24865167 |
2014 |
Alcoholic Intoxication, Chronic
|
0.340 |
Biomarker
|
disease |
PSYGENET |
In AAs, 2 CpGs in 2 genes (GABRB3 and POMC) were hypermethylated in AD cases compared with controls (p ≤ 0.001).
|
22924764 |
2013 |
Alcoholic Intoxication, Chronic
|
0.340 |
Biomarker
|
disease |
PSYGENET |
In the present study, A1+ (A1A1 and A1A2 genotypes) and A1- (A2A2 genotype) alleles of the DRD2 and G1+ (G1G1 and G1 non-G1 genotypes) and G1- (non-G1 non-G1 genotype) alleles of the GABRB3 gene were determined in a group of 56 medically ill patients diagnosed with alcohol dependence.
|
15296817 |
2004 |
Alcoholic Intoxication, Chronic
|
0.340 |
Biomarker
|
disease |
PSYGENET |
However, when the DRD2 and the GABRB3 variants are combined, the risk for alcoholism is more robust than when these variants are considered separately.
|
9858031 |
1998 |
Alcoholic Intoxication, Chronic
|
0.340 |
Biomarker
|
disease |
PSYGENET |
Polymorphisms of the dopamine D2 receptor, serotonin transporter, and GABA(A) receptor beta(3) subunit genes and alcoholism in Mexican-Americans.
|
15066703 |
2004 |
Mental Depression
|
0.330 |
Biomarker
|
disease |
PSYGENET |
In conclusion, the present study indicates that in a population of PTSD patients, heterozygosity of the GABRB3 major (G1) allele confers higher levels of somatic symptoms, anxiety/insomnia, social dysfunction and depression than found in homozygosity.
|
11711165 |
2001 |
Mental Depression
|
0.330 |
Biomarker
|
disease |
PSYGENET |
The rs4906902 G allele of the GABRB3 gene was overrepresented in mTLE patients with depression; individuals homozygous for the G allele showed reduced GABRB3 mRNA expression.
|
22082659 |
2011 |
Mental Depression
|
0.330 |
Biomarker
|
disease |
PSYGENET |
Patients carrying the GABRB3 G1+ allele showed stronger AE relating to negative affective change (for example, increased depression) than their GABRB3 G1- counterparts.
|
15296817 |
2004 |